Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/1999
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/12/1999CA2310041A1 Lipid mixtures and their use
08/11/1999EP0934954A1 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934742A2 High glycerin containing anti-microbial cleansers
08/11/1999EP0934741A1 Hair growth stimulants
08/11/1999EP0934314A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934313A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934312A1 1,4-disubstituted piperazines
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934295A1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics
08/11/1999EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0934055A1 Clear cosmetic sticks and process for its preparation
08/11/1999EP0934053A1 Cosmetic or dermatological microemulsions
08/11/1999EP0584171B1 Composition and method of treating depigmentation disorders
08/11/1999CN1225654A Angiogenic inhibitory compounds
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225575A Method for althering hair growth and hair pigmentation and compositions therefor
08/10/1999US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors
08/10/1999US5936067 Macrophage inflammatory protein variants
08/10/1999US5936065 CS-1 peptidomimetics, compositions and methods of using the same
08/10/1999US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin
08/10/1999US5935585 Novel compounds useful in topical and systemic treatment of dermatological conditions associated with a keratinization disorder, and inflammatory or immunoallergenic component; body and hair care cosmetics
08/05/1999WO1999039045A1 Aqueous compositions comprising complexing agents and uses therof
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038858A1 Benzo[b]pyran derivatives useful as external agents for the skin
08/05/1999WO1999038850A1 Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038531A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
08/05/1999WO1999038513A1 R-lansoprazole compositions and methods
08/05/1999WO1999038512A1 S-lansoprazole compositions and methods
08/05/1999WO1999038495A2 Controlled release delivery of peptide or protein
08/05/1999WO1999038484A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999WO1999038479A1 Banana peel extract composition and method for extraction
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999021860B1 Phenanthroline derivatives
08/05/1999WO1999020121A9 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue
08/05/1999DE19804376A1 Lipidmischungen sowie deren Verwendung Lipid mixtures and their use
08/05/1999DE19804301A1 Tincture for treating inflammatory skin and mucosal disorders, especially mouth ulcers
08/05/1999CA2335037A1 Aqueous compositions comprising complexing agents and uses thereof
08/05/1999CA2320963A1 R-lansoprazole compositions and methods
08/05/1999CA2320902A1 S-lansoprazole compositions and methods
08/05/1999CA2318780A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999CA2318343A1 Benzo[b]pyran derivatives useful as external agents for the skin
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0932410A1 Mistletoe (viscum) extracts
08/04/1999EP0932387A1 Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid
08/04/1999EP0737176B1 Process for isomerizing linear olefins to isoolefins
08/04/1999EP0585242B1 Wound healing
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1224718A Thiazole derivatives
08/04/1999CN1224619A Novel powder compositions
08/04/1999CN1224617A External-use medicine for curing various chronic ulcers
08/04/1999CN1224612A Eye bag & wrinkles eliminating medicine and its preparation
08/03/1999US5932728 Antihistamines; antiallergens
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932593 Antiserotonin agent
08/03/1999US5932576 3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
08/03/1999US5932565 Vitamin D analogues
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932236 Pharmaceutical composition and methods for using it
08/03/1999US5932232 Product for topical application containing a lipase and an active ingredient precursor
08/03/1999US5932216 Antibodies to bone morphogenetic protein-10 (BMP-10)
08/03/1999US5932215 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema
07/1999
07/29/1999WO1999037751A1 Purified populations of stem cells
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037668A1 Thrombin inhibitors
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037622A1 Nitrogenous heterocyclic derivatives and medicine thereof
07/29/1999WO1999037619A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037617A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037616A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
07/29/1999WO1999037319A1 Method for treating inflammatory diseases using heat shock proteins
07/29/1999WO1999037314A1 Sea cucumber carotenoid lipid fraction products and methods of use
07/29/1999WO1999037300A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
07/29/1999WO1999012968A3 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
07/29/1999WO1998050530A3 Enzymatic nucleic acids: synthesis, selection and use
07/29/1999DE19802708A1 Use of 1-hydroxy-2-pyridone compounds with powder base for treatment of lower leg ulcers and decubitus ulcers
07/29/1999CA2319077A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318303A1 Secreted proteins and polynucleotides encoding them
07/29/1999CA2318263A1 Method for treating inflammatory diseases using heat shock proteins
07/29/1999CA2318100A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2318088A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999CA2317761A1 Thrombin inhibitors
07/29/1999CA2311729A1 Purified populations of stem cells
07/28/1999EP0931788A2 Metalloprotease inhibitors
07/28/1999EP0931542A1 Cosmetic composition containing phloroglucinol
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1065